Javascript must be enabled to continue!
Frequency of Phototherapy-Induced Hypocalcemia in Neonates with Unconjugated Hyperbilirubinemia
View through CrossRef
Background: Phototherapy remains the cornerstone in the management of neonatal unconjugated hyperbilirubinemia. While effective and widely used, it is not devoid of adverse effects. Objective: To determine the frequency of hypocalcemia in full-term neonates receiving phototherapy for unconjugated hyperbilirubinemia and to evaluate its clinical manifestations and associated factors. Methods: This prospective observational study was conducted at the Department of Pediatrics, Chaudhary Muhammad Akram Teaching and Research Hospital, Lahore from 12-6-24 to 12-12-24. A total of 125 full-term neonates requiring phototherapy were enrolled using non-probability consecutive sampling. Neonates with perinatal asphyxia, prior hypocalcemia, suspected hemolysis, or maternal diabetes were excluded. Phototherapy was administered according to AAP 2022 guidelines using narrow-spectrum LED blue light. Serum total calcium and bilirubin levels were measured pre-treatment and two hours post-therapy. Results: Out of 125 neonates, 32 (25.6%) developed hypocalcemia after phototherapy. Among these, 12 neonates (37.5%) were symptomatic, presenting with jitteriness (n=6), apnea (n=3), and irritability (n=3). The mean pre- and post-phototherapy calcium levels were 9.42 ± 0.58 mg/dL and 8.12 ± 0.76 mg/dL, respectively. A significant association was found between hypocalcemia and phototherapy duration >24 hours (p = 0.018). Conclusion: Phototherapy-induced hypocalcemia is a common and clinically relevant complication in term neonates treated for unconjugated hyperbilirubinemia. Routine post-therapy calcium monitoring, especially in those undergoing extended phototherapy, is strongly recommended to detect and manage this preventable adverse outcome.
Title: Frequency of Phototherapy-Induced Hypocalcemia in Neonates with Unconjugated Hyperbilirubinemia
Description:
Background: Phototherapy remains the cornerstone in the management of neonatal unconjugated hyperbilirubinemia.
While effective and widely used, it is not devoid of adverse effects.
Objective: To determine the frequency of hypocalcemia in full-term neonates receiving phototherapy for unconjugated hyperbilirubinemia and to evaluate its clinical manifestations and associated factors.
Methods: This prospective observational study was conducted at the Department of Pediatrics, Chaudhary Muhammad Akram Teaching and Research Hospital, Lahore from 12-6-24 to 12-12-24.
A total of 125 full-term neonates requiring phototherapy were enrolled using non-probability consecutive sampling.
Neonates with perinatal asphyxia, prior hypocalcemia, suspected hemolysis, or maternal diabetes were excluded.
Phototherapy was administered according to AAP 2022 guidelines using narrow-spectrum LED blue light.
Serum total calcium and bilirubin levels were measured pre-treatment and two hours post-therapy.
Results: Out of 125 neonates, 32 (25.
6%) developed hypocalcemia after phototherapy.
Among these, 12 neonates (37.
5%) were symptomatic, presenting with jitteriness (n=6), apnea (n=3), and irritability (n=3).
The mean pre- and post-phototherapy calcium levels were 9.
42 ± 0.
58 mg/dL and 8.
12 ± 0.
76 mg/dL, respectively.
A significant association was found between hypocalcemia and phototherapy duration >24 hours (p = 0.
018).
Conclusion: Phototherapy-induced hypocalcemia is a common and clinically relevant complication in term neonates treated for unconjugated hyperbilirubinemia.
Routine post-therapy calcium monitoring, especially in those undergoing extended phototherapy, is strongly recommended to detect and manage this preventable adverse outcome.
Related Results
Phototherapy-Induced Hypocalcemia in Icteric Term Neonates
Phototherapy-Induced Hypocalcemia in Icteric Term Neonates
Neonatal jaundice requiring phototherapy is a common condition, but phototherapy has been associated with potential side effects, including hypocalcemia. Understanding the frequenc...
Cylindrical intensive vs. double surface LED phototherapy for neonatal hyperbilirubinemia
Cylindrical intensive vs. double surface LED phototherapy for neonatal hyperbilirubinemia
Background High bilirubin levels may lead to complications such as bilirubin encephalopathy or even death. Therefore, neonatal hyperbilirubinemia patients require appropriate treat...
A study on effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia: a hospital based prospective observational study
A study on effect of phototherapy on platelet count in neonates with unconjugated hyperbilirubinemia: a hospital based prospective observational study
Background: Thrombocytopenia as a side effect of phototherapy has not been mentioned in standard literature and textbooks. Though there are few studies in this regard, but results ...
Phototherapy Induced Hypocalcemia in Term and Preterm Neonates with Hyperbilirubinemia: A Cross-Sectional Study
Phototherapy Induced Hypocalcemia in Term and Preterm Neonates with Hyperbilirubinemia: A Cross-Sectional Study
Introduction: Neonatal jaundice is a common condition affecting 60% of term and 80% of preterm neonates within the first week of life. Phototherapy, though the standard treatment f...
EFFECT OF PHOTOTHERAPY ON SERUM ELECTROLYTESIN NEONATES ≥35 WEEKS OF GESTATION WITH HYPERBILIRUBINEMIA
EFFECT OF PHOTOTHERAPY ON SERUM ELECTROLYTESIN NEONATES ≥35 WEEKS OF GESTATION WITH HYPERBILIRUBINEMIA
Background:Neonatal hyperbilirubinemia is common (≈60% of term and 85% of preterm infants) and can lead to neurotoxicity or kernicterus if untreated. Phototherapy is the s...
The Role of Oral Phenobarbital Therapy in the Management of Neonates with Prolonged Unconjugated Hyperbilirubinemia
The Role of Oral Phenobarbital Therapy in the Management of Neonates with Prolonged Unconjugated Hyperbilirubinemia
Background: Prolonged jaundice is a type of neonatal jaundice, which occurs in infants with high bilirubin levels (>10 mg/dl) persisting beyond day 14 of life in term neonates, ...
Does Gender Affect Levels of Hyperbilirubinemia in Term Neonates
Does Gender Affect Levels of Hyperbilirubinemia in Term Neonates
Introduction: Hyperbilirubinemia is a common & in most1cases, benign problem in1first month of1life which is often1physiologic & intervention is not1usually1necessary. In t...
Estimation of malondialdehyde and vitamin-E levels in neonatal hyperbilirubinemia before and after phototherapy
Estimation of malondialdehyde and vitamin-E levels in neonatal hyperbilirubinemia before and after phototherapy
Hyperbilirubinemia is a common and benign problem in neonates worldwide. It is observed during the 1st week of life in approximately 60% of term neonates and 80% of pretenn neonate...

